| 产品名称： | Coxsackievirus A21 antiserum V-024-501-563 |
|---|---|
| 商品货号： | TS162465 |
| Deposited As： | Coxsackievirus A21 |
| Agent： | Coxsackievirus A21 antiserum V-024-501-563 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried 0.5 mL |
| Storage Conditions： | 4°C |
| Comments： | Immunogen: Picornavirus, Enterovirus, Coxsackievirus A21, and Strain Kuykendall Source of antibody: Rhesus monkey Propagated in: human amnion cells in tissue culture Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus |
| Name of Depositor： | NIH/NIAID, University of Kanasas Medical Center |
| Source： | Monkey immune serum prepared against Coxsackievirus A 21 strain Kuykendall |
| References： | Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414 Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Coxsackievirus A21 antiserum V-024-501-563 |
|---|---|
| 商品货号： | TS162465 |
| Deposited As： | Coxsackievirus A21 |
| Agent： | Coxsackievirus A21 antiserum V-024-501-563 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried 0.5 mL |
| Storage Conditions： | 4°C |
| Comments： | Immunogen: Picornavirus, Enterovirus, Coxsackievirus A21, and Strain Kuykendall Source of antibody: Rhesus monkey Propagated in: human amnion cells in tissue culture Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus |
| Name of Depositor： | NIH/NIAID, University of Kanasas Medical Center |
| Source： | Monkey immune serum prepared against Coxsackievirus A 21 strain Kuykendall |
| References： | Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414 Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925 |
